相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ATTEC: a potential new approach to target proteinopathies
Zhaoyang Li et al.
AUTOPHAGY (2020)
Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
Maria Maneiro et al.
ACS CHEMICAL BIOLOGY (2020)
Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik et al.
NATURE (2020)
Targeted glycan degradation potentiates the anticancer immune response in vivo
Melissa A. Gray et al.
NATURE CHEMICAL BIOLOGY (2020)
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
Behnam Nabet et al.
NATURE COMMUNICATIONS (2020)
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
Ji-Hua Shi et al.
CANCER MEDICINE (2019)
Interactive Peptide Spectral Annotator: A Versatile Web-based Tool for Proteomic Applications
Dain R. Brademan et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds
Zhaoyang Li et al.
NATURE (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Daiki Takahashi et al.
MOLECULAR CELL (2019)
Enhanced Global Post-translational Modification Discovery with MetaMorpheus
Stefan K. Solntsev et al.
JOURNAL OF PROTEOME RESEARCH (2018)
The dTAG system for immediate and target-specific protein degradation
Behnam Nabet et al.
NATURE CHEMICAL BIOLOGY (2018)
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Aaron D. Springer et al.
NUCLEIC ACID THERAPEUTICS (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
Well-Defined Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor
Xiangang Huang et al.
BIOCONJUGATE CHEMISTRY (2017)
Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
Byron H. Kwan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Clinical Proof of Concept for a Novel Hepatocyte-Targeting GaINAc-siRNA Conjugate
Tracy S. Zimmermann et al.
MOLECULAR THERAPY (2017)
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Kevin Fitzgerald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Yuanyu Huang
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
A Method for the Acute and Rapid Degradation of Endogenous Proteins
Dean Clift et al.
CELL (2017)
Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation
Nick Cox et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
Shigeo Matsuda et al.
ACS CHEMICAL BIOLOGY (2015)
A Calibration Routine for Efficient ETD in Large-Scale Proteomics
Christopher M. Rose et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
OPN and αvβ3 Expression are Predictors of Disease Severity and Worse Prognosis in Hepatocellular Carcinoma
Yi Jin et al.
PLOS ONE (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Hydrazino-Pictet-Spengler Ligation as a Biocompatible Method for the Generation of Stable Protein Conjugates
Paresh Agarwal et al.
BIOCONJUGATE CHEMISTRY (2013)
Delivery materials for siRNA therapeutics
Rosemary Kanasty et al.
NATURE MATERIALS (2013)
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
Zakaria Ezzoukhry et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
Marie-Jose Blivet-Van Eggelpoel et al.
JOURNAL OF HEPATOLOGY (2012)
Site-specific chemical protein conjugation using genetically encoded aldehyde tags
David Rabuka et al.
NATURE PROTOCOLS (2012)
CD22 Is a Recycling Receptor That Can Shuttle Cargo between the Cell Surface and Endosomal Compartments of B Cells
Mary K. O'Reilly et al.
JOURNAL OF IMMUNOLOGY (2011)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Engineered cystine knot peptides that bind αvβ3, αvβ5, and α5β1 integrins with low-nanomolar affinity
Richard H. Kimura et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Antisense integrin αV and β3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas
J. Li et al.
DIGESTIVE AND LIVER DISEASE (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acidα2,6GalNAc
EI Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck
J Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mannose 6-phosphate receptors: New twists in the tale
P Ghosh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes
MA Arangoa et al.
GENE THERAPY (2003)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
